Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valerian for prevention of neuropsychiatric adverse effects of Efavirenz in HIV positive patients
IRCT201504053449N18Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2015
- Countries
- 1
01
Overview
Phase 3 trial of valeriana officinalis in neurobehavioral conditions and human immunodeficiency virus infection (HIV), sponsored by Tehran University of Medical Sciences. Started Sep 2015; status: completed.
02
Drugs
valeriana officinalis
03
Conditions
neurobehavioral conditionshuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on IRCT201504053449N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201504053449N18.